Nutritional Status and Its Detection in Patients with Inflammatory Bowel Diseases Original paper
-
Autoimmune Diseases
Autoimmune Diseases
Autoimmune disease is when the immune system mistakenly attacks the body's tissues, often linked to imbalances in the microbiome, which can disrupt immune regulation and contribute to disease development.
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What was studied?
This paper focuses on nutritional status and its detection in patients with inflammatory bowel diseases (IBD), specifically Crohn’s disease (CD) and ulcerative colitis (UC). It explores the mechanisms leading to malnutrition in IBD, including altered digestion, malabsorption, and drug-nutrient interactions. The study also evaluates various screening tools used to assess the nutritional risk in these patients.
Who was studied?
The study involved patients diagnosed with IBD, including both those with active disease and those in remission. These patients face a higher risk of malnutrition, often due to disease-related complications like malabsorption, diarrhea, and changes in appetite. The review also looks into the impact of disease activity on nutritional status, with a focus on IBD-related nutrient deficiencies, including deficiencies in vitamins like B12 and D, as well as minerals such as iron, zinc, and magnesium.
Most important findings
The review highlights several crucial findings regarding malnutrition in IBD patients. It emphasizes the importance of regular nutritional screening, particularly using tools like the Saskatchewan Inflammatory Bowel Disease–Nutrition Risk Tool (SaskIBD-NR Tool) and the IBD-specific Nutritional Screening Tool (IBD-NST). These tools are useful for identifying nutritional risk before the onset of severe malnutrition. Nutrient deficiencies, particularly in vitamin B12, folate, iron, and zinc, were found to be prevalent in IBD patients, with CD patients being more vulnerable to deficiencies like vitamin B12 due to the common ileocecal location of the disease. Additionally, the use of anti-TNFα therapy, such as infliximab, was shown to improve nutritional status in IBD patients, with better outcomes observed when nutritional status was optimized before therapy.
Key implications
The findings of this study have important implications for both clinical practice and research. For clinicians, this paper underscores the need for routine and specific nutritional screenings in IBD patients to identify those at risk of malnutrition early, allowing for timely interventions. It also points out the significance of dietary and pharmacological interventions, such as the use of anti-TNFα therapy, in improving nutritional outcomes. For researchers, the study calls for further validation of IBD-specific nutritional screening tools and the exploration of the relationship between nutritional status and disease outcomes, particularly in the context of surgery and long-term disease management.
Crohn’s Disease
Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract that can cause a wide range of symptoms, including abdominal pain, diarrhea, and fatigue. The exact cause of the disease remains unclear, but it is believed to result from a combination of genetic predisposition and environmental factors. Although there is no cure, ongoing advancements in medical research continue to improve management strategies and quality of life for those affected by Crohn's disease.